Hantz Financial Services’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.97M | Sell |
31,457
-76,910
| -71% | -$6.15M | 0.03% | 335 |
|
|
2025
Q4 | $10.3M | Sell |
108,367
-16,673
| -13% | -$1.63M | 0.15% | 104 |
|
|
2025
Q3 | $12.2M | Buy |
125,040
+84,953
| +212% | +$8.8M | 0.18% | 90 |
|
|
2025
Q2 | $4.31M | Sell |
40,087
-1,825
| -4% | -$185K | 0.07% | 227 |
|
|
2025
Q1 | $4.23M | Buy |
41,912
+8,808
| +27% | +$887K | 0.07% | 223 |
|
|
2024
Q4 | $2.96M | Sell |
33,104
-263
| -0.8% | -$23.2K | 0.05% | 277 |
|
|
2024
Q3 | $2.8M | Buy |
33,367
+263
| +0.8% | +$20.7K | 0.05% | 292 |
|
|
2024
Q2 | $2.55M | Buy |
33,104
+65
| +0.2% | +$4.76K | 0.05% | 295 |
|
|
2024
Q1 | $2.26M | Buy |
33,039
+205
| +0.6% | +$13.2K | 0.04% | 326 |
|
|
2023
Q4 | $1.9M | Buy |
32,834
+844
| +3% | +$45.1K | 0.04% | 341 |
|
|
2023
Q3 | $1.69M | Buy |
31,990
+27,026
| +544% | +$1.42M | 0.04% | 334 |
|
|
2023
Q2 | $269K | Hold |
4,964
| – | – | 0.01% | 520 |
|
|
2023
Q1 | $248K | Hold |
4,964
| – | – | 0.01% | 526 |
|
|
2022
Q4 | $230K | Buy |
4,964
+4,211
| +559% | +$182K | 0.01% | 525 |
|
|
2022
Q3 | $29K | Hold |
753
| – | – | ﹤0.01% | 638 |
|
|
2022
Q2 | $28K | Sell |
753
-20
| -3% | -$814 | ﹤0.01% | 637 |
|
|
2022
Q1 | $34K | Sell |
773
-56,040
| -99% | -$2.43M | ﹤0.01% | 643 |
|
|
2021
Q4 | $2.41M | Buy |
56,813
+3,748
| +7% | +$157K | 0.07% | 251 |
|
|
2021
Q3 | $2.3M | Buy |
53,065
+7,808
| +17% | +$345K | 0.08% | 233 |
|
|
2021
Q2 | $1.94M | Buy |
45,257
+1,084
| +2% | +$45.6K | 0.07% | 245 |
|
|
2021
Q1 | $1.71M | Buy |
44,173
+408
| +0.9% | +$15.4K | 0.07% | 243 |
|
|
2020
Q4 | $1.57M | Buy |
+43,765
| New | +$1.58M | 0.07% | 235 |
|
Other funds holding BSX
VCM
VPM
